NCT05228691Recruiting
Prevalence of Long COVID-19 in the Canary Islands
Long COVID: Evaluation of Physical and Functional Status
Source: ClinicalTrials.gov · Last updated 28 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
With more than 246 million people diagnosed with coronavirus 2019 (COVID-19) around the world, many of whom have required medical attention for past 23 months, greater emphasis is being placed on post-acute care of COVID-19 survivors. According to recent data, millions of patients who have recovered from acute COVID-19 are experiencing persistent symptoms, which lead to disability and impaired activities of daily living. Various terms have been used to describe the condition of patients who do not return to their initial health status to include post-acute sequelae of COVID-19, such as post-acute COVID syndrome (PACS) and Long COVID. The growing global burden of COVID-19 suggests that the potential effects of Long COVID in public health are vast even if Long COVID is experienced by a small proportion of patients recovering from acute infection. The ability to identify patients at high risk for Long COVID and forecasting medical resource requirements is of important clinical utility in the present. In view of the large number of people surviving after infection with COVID-19 and that should require follow-up, determine which patients are at risk of have Long COVID and who require close monitoring is crucial. In this study, therefore, we set out to analyze what type of patient profile with COVID-19 who, after 12 weeks of having suffered the infection, experiences the signs and symptoms described by current literature.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 600 (estimated)
- First submitted
- 5 Feb 2022
- Start date
- 22 Mar 2022
- Primary completion date
- 22 Dec 2025
- Lead sponsor
- University of Las Palmas de Gran Canaria
- Diseases
- Long COVID and ME/CFS
- NCT number
- NCT05228691
What you commit to
- Study type: Observational
- Planned participants: 600
- From 22 Mar 2022 to the primary completion date, 22 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Present comorbidities prior to suffering from COVID-19 whose symptoms are resemble Post-acute COVID-19.
Other illness
- Neuromuscular disease.
- Person undergoing treatment for active cancer.
Other
- Fibromyalgia.
- Chronic fatigue.
- Not having signed the informed consent.
Who the study is looking for
- Have been positive for COVID-19 since the declaration of the state of alarm throughout the Spanish territory to deal with the health emergency situation caused by COVID-19 (March 14, 2020).
- Symptoms associated with COVID-19 at least after 12 weeks of its detection.
- Adequate cognitive and physical level to understand and perform the tests evaluation.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Las Palmas de Gran Canaria Coordinator of this site? Confirm its status | Las Palmas de Gran Canaria | Spain | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.